Microsoft Word 02Preface doc

2)
 
Increasing the Screening Rate of Blood for Transfusions   
HEPCELL II, a diagnostic kit for Hepatitis B developed by KEMRI, has been 
distributed to provincial hospitals and blood banks through NPHLS since 2002.  
There were 400 kits and 1,000 kits distributed in 2002 and 2003, respectively.     
As mentioned previously, medicines and reagents distributed by NPHRS are purchased 
through tender.    HEPCELL II has an advantage over competing diagnostic kits from 
the financial aspects, although the results of the tender for 2004 were not announced 
during the period of the field survey (see Table 5.14).